Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route-Reference-Cited by-同舟云学术

Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route

Published:2016-09-15 Issue:9 Volume:11 Page:e0163240
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Oliveira Edson R. A.,Gonçalves Antônio J. S.,Costa Simone M.,Azevedo Adriana S.,Mantuano-Barradas Marcio,Nogueira Ana Cristina M. A.,Alves Ada M. B.^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Instituto Nacional de Ciência e Tecnologia de Vacinas (BR)

Programa de Desenvolvimento Tecnológico em Insumos para Saúde - FIOCRUZ (BR)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. The global distribution and burden of dengue;S Bhatt;Nature,2013

2. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control,2009

3. The economic burden of dengue;DJ Gubler;Am J Trop Med Hyg,2012

4. Fields Virology;BD Lindebach,2001

5. Production of immunity to dengue with virus modified by propagation in mice;AB Sabin;Science,1945

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bivalent form of nanoparticle-based dengue vaccine stimulated responses that potently eliminate both DENV-2 particles and DENV-2-infected cells;Vaccine;2023-02

2. Potential use of Annona (Annonaceae) by-products to Palpita forficifera management: Lethal and sublethal toxicities and residual effect in olive plants;Crop Protection;2022-10

3. Generation and Characterization of Human-Mouse STING Chimeras That Allow DENV Replication in Mouse Cells;mSphere;2022-06-29

4. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein;Vaccine;2022-04

5. Targets and strategies for vaccine development against dengue viruses;Biomedicine & Pharmacotherapy;2021-12